Suggest case paper study on topic of operative procedure for obs and gynec resident
| Name | Mrs. X |
| Age | 42 years |
| Parity | P3L3 |
| MRD No. | _____ |
| Date of Admission | _____ |
| Date of Operation | _____ |
| Surgeon | Dr. _____ |
| Resident (1st Assist) | Dr. _____ |
| Anaesthetist | Dr. _____ |
| Anaesthesia | Spinal / General |
| Item | Detail |
|---|---|
| Consent | Written informed consent obtained; risks (bleeding, injury to bladder/ureter/bowel, vault prolapse, early menopause if BSO done) explained |
| Bowel prep | Enema night before / day of surgery |
| Bladder | Foley catheter inserted in OT |
| IV access | Wide-bore (18G) IV cannula x2 |
| Blood | Group & screen; 2 units PRBC cross-matched and reserved |
| Antibiotics | Inj. Cefazolin 1 g IV 30 min before incision (prophylaxis) |
| VTE prophylaxis | TED stockings / LMWH as per protocol |
| Shaving | Infra-umbilical area shaved on the morning of surgery |
| Positioning | Supine with slight Trendelenburg |
| Finding | Details |
|---|---|
| Uterus | Bulky, irregular surface, ____ weeks size, mobile/fixed |
| Fibroids | Multiple/solitary; intramural/subserosal/submucosal; largest ___cm at ___location |
| Tubes | Normal / Hydrosalpinx |
| Ovaries | Normal / Cyst noted |
| Adhesions | Nil / Dense omental/bowel adhesions (state) |
| Blood loss | Approximately ___mL |
| Specimen weight | ___grams |
| Monitoring | Pulse, BP, SpO2, urine output q 1 hourly x 6 hrs |
| IV fluids | RL 1L q 8 hrly for 24 hours; oral fluids when fully awake |
| Analgesia | Inj. Diclofenac 75 mg IM q 12 hrly; Paracetamol 1g IV q 8 hrly |
| Antibiotics | Continue Inj. Cefazolin 1g IV q 8 hrly for 24 hrs |
| Catheter | Keep for 24 hrs; remove next morning if urine clear |
| Diet | Liquids Day 1, soft diet Day 2 |
| Ambulation | Sit up in 6 hrs; walk with assistance on Day 1 |
| Wound | Inspect Day 2; sutures/staples out Day 7-10 |
| Discharge | Day 3-5 if uncomplicated |
| Histopathology | Specimen sent for HPE - report to be collected |
Search PubMed for recent complication rates and management of TAH vs alternatives
"hysterectomy"[MeSH Terms] AND "postoperative complications"[MeSH Terms]
"abdominal hysterectomy"[MeSH Terms] AND "laparoscopic hysterectomy"[MeSH Terms]
"uterine fibroids"[MeSH Terms] AND "hysterectomy"[MeSH Terms] AND "myomectomy"[MeSH Terms]
"hysterectomy" AND "laparoscopic" AND "complications" AND "abdominal"
"leiomyoma" AND "hysterectomy" AND "myomectomy" AND "outcomes"
PMID: 38743951
PMID: 37642285
PMID: 39088416
PMID: 39164326
PMID: 40183418
| Outcome | AH (TAH) | VH | LH |
|---|---|---|---|
| Return to normal activity | Reference (37-42 days) | ~10-11 days faster (mod. certainty) | ~13 days faster (low certainty) |
| Urinary tract injury | Reference (~0.2%) | Similar to AH | 2x higher (OR 2.16; 95% CI 1.19-3.93) |
| Operative time | Shorter than LH | Shorter than LH | Longer |
| Hospital stay | Longer | Shorter | Shorter |
| Fistula, sexual dysfunction | No significant difference across routes |
| Comparison | Finding |
|---|---|
| TAH vs Robotic-assisted | TAH had 6x higher blood transfusion risk (OR 6.31; 95% CI 1.07-37.32) |
| TLH vs VH | TLH had 7.5x higher ureteric injury risk (OR 7.54; 95% CI 2.52-22.58) |
| VH vs LAVH | VH was ~39 min faster; shorter hospital stay |
| VH vs TLH | VH was ~50 min faster |
| Minimally invasive overall | Lower blood loss, shorter stay vs abdominal route |
| Risk Factor | OR (95% CI) | Management Implication |
|---|---|---|
| Perioperative transfusion | 4.50 (3.29-6.16) | Minimize blood loss; cell salvage |
| Opioid use | 3.91 (1.08-14.24) | Multimodal analgesia; reduce opioids |
| Concomitant bowel surgery | 3.79 (1.86-7.71) | Anticipate; ERAS protocol |
| General anaesthesia | 2.73 (1.60-4.66) | Prefer spinal/regional where possible |
| Dysmenorrhea (pre-op) | 2.51 (1.25-5.05) | Flag high-risk patients pre-op |
| Outcome at 4-year follow-up | UAE | Myomectomy | Significance |
|---|---|---|---|
| Reintervention rate | Higher | Lower | OR 1.84 (1.62-2.10), p<0.01 |
| Eventual hysterectomy rate | Higher | Lower | OR 4.04 (3.45-4.72), p<0.01 |
| Symptom severity score | Worse | Better | OR -4.02 (0.82-7.22), p=0.01 |
| Early complications | Lower | Higher | OR 0.44 (0.20-0.95), p=0.04 |
| Hospital readmission | Lower | Higher | OR 1.16 (1.01-1.33) |
| Pregnancy rates | Comparable | Comparable | - |
| Agent | Key Evidence | Recommendation |
|---|---|---|
| GnRH analogues (e.g., leuprolide, triptorelin) | Reduce uterine volume (-175 mL), increase pre-op Hb (+0.88 g/dL), shorten operative time (-10 min) | Useful 2-3 months pre-op in anaemic patients; offset by side effects (OR 2.78 for adverse events) |
| Ulipristal acetate (SPRM) | Effective fibroid shrinkage | Currently suspended (March 2025) due to hepatotoxicity/liver failure association |
| Iron supplementation | Corrects anaemia before surgery | Standard pre-op protocol |
| Parameter | TAH | VH | TLH/LAVH | Robotic |
|---|---|---|---|---|
| Return to activity | 37-42 days | ~28 days | ~24 days | ~24 days |
| Blood loss (large uterus) | Highest | Moderate | Lower | Lowest |
| Ureteric injury | ~0.2% | ~0.2% | ~2% (10x higher vs VH in large uterus) | Low |
| Post-op ileus | Higher risk | Lower risk | Lower risk | Lower risk |
| Operative time (large uterus) | Shortest | Moderate | Longest | Long |
| Suitable for large fibroids | Yes (standard) | Limited | With expertise | With expertise |
| Reintervention (vs UAE) | Definitive | Definitive | Definitive | Definitive |
Create a comparison table/infographic (TAH vs VH vs TLH vs Robotic)
A clean medical infographic comparison table for OB/GYN residents comparing four types of hysterectomy: TAH (Total Abdominal Hysterectomy), VH (Vaginal Hysterectomy), TLH (Total Laparoscopic Hysterectomy), and Robotic Hysterectomy. The infographic should have a professional dark navy blue header with white title text "Hysterectomy Approaches: A Resident's Comparison Guide". Four columns, one per approach, each with a distinct color: TAH in red/coral, VH in green, TLH in blue, Robotic in purple. Each column should show a small icon representing the approach at the top (scalpel for TAH, downward arrow for VH, laparoscope for TLH, robotic arm for Robotic). Rows comparing the following parameters with short factual text in each cell: 1. Incision - TAH: Low transverse or midline | VH: No abdominal incision | TLH: 3-4 small ports | Robotic: 4-5 ports + robot docking 2. Best Indication - TAH: Large/bulky uterus, adhesions | VH: Prolapse, normal-sized uterus | TLH: Moderate size, endometriosis | Robotic: Complex cases, obesity 3. Blood Loss - TAH: Highest (6x vs Robotic) | VH: Moderate | TLH: Low | Robotic: Lowest 4. Return to Activity - TAH: 37–42 days | VH: ~28 days | TLH: ~24 days | Robotic: ~24 days 5. Ureteric Injury Risk - TAH: ~0.2% | VH: ~0.2% | TLH: Up to 2% (7.5x vs VH) | Robotic: Low 6. Post-op Ileus Risk - TAH: Highest | VH: Low (OR 0.35) | TLH: Low (OR 0.43) | Robotic: Low 7. Hospital Stay - TAH: 3–5 days | VH: 1–2 days | TLH: 1–2 days | Robotic: 1–2 days 8. Operative Time (large uterus) - TAH: Shortest | VH: Short-Moderate | TLH: Longest | Robotic: Long 9. Cost - TAH: Low | VH: Low | TLH: Moderate | Robotic: Highest 10. Learning Curve - TAH: Easy | VH: Moderate | TLH: Steep | Robotic: Steepest 11. Suitable for Obesity - TAH: Difficult | VH: Difficult | TLH: Moderate | Robotic: Best 12. Evidence Source - TAH: Cochrane 2023, Mamik 2024 | VH: Cochrane 2023 | TLH: Cochrane 2023, Mamik 2024 | Robotic: Mamik 2024 At the bottom, a footer banner in dark navy: "Sources: Cochrane 2023 [PMID 37642285] | Mamik et al. 2024 [PMID 38743951] | Hou et al. 2024 [PMID 39088416]" Use alternating light/white row backgrounds for readability. Professional medical typography, clear hierarchy, suitable for printing on A4.